Henri Steenkamp
Analyst · Ladenburg. Your line is open
Thank you, Chris. Slide 4 highlights our key performance metrics for the fourth quarter ended February 28, 2022. When adjusting for the incentive fee accrual related to net capital gains and the second incentive fee calculation, adjusted NII of $6.4 million dollars was up 4.3% from $6.1 million last quarter, and up 9.9% from $5.8 million, as compared to last year's as Q4. Adjusted NII per share was $0.53, up $0.01 from $0.52 per share last year, and unchanged from last quarter. Across the three quarters weighted average common shares outstanding were $12.0 million for this quarter, $11.4 5 million for last quarter, and $11.2 million for last year's Q4. The equity issuances above NAV we did in Q3 and Q4 under our ATM program resulted in a $0.02 dilution to NII per share this quarter, and reflects the impact to earnings while this capital is still undeployed. The increase in adjusted NII from last year primarily reflects the higher level of investments and resultant high interest and other income, with AUM up 24% since last quarter, offset by lower absolute interest rates with a weighted average current coupon on non-CLO BDC investments decreasing from 9.6% to 8.5% year-over-year. Adjusted NII yield was 7.3%. This yield is down 40 basis points from 7.7% last year and unchanged from 7.3% last quarter. For this fourth quarter, we experienced a net gain on investments of $2.7 million or $0.23 per weighted average share and a $0.1 million realized loss on the repayment of SBIC I debentures or $0.01 per weighted average share, resulting in a total increase in net assets from operations of $8.4 million or $0.70 per share. The $2.7 million dollars net gain on investments was comprised of $0.1 million in net realized gains and $2.9 million in net unrealized appreciation offset by $0.2 million of deferred tax expense on unrealized appreciation. The $0.1 million dollars net realized gain comprises an escrow payment to $2.9 million net unrealized appreciation primarily reflects, first $1.9 million unrealized appreciation on the company's PDDS preferred stock investment, a $1.0 million unrealized appreciation on the company's Artemis Wax preferred equity investments, $0.8 million unrealized appreciation on the company's Netreo investment and $1.0 million unrealized appreciation on the company's Destiny equity investment, partially offset by the $1.6 million and $1.1 million unrealized appreciation on the company's CLO and JV equity investments respectively. This depreciation reflects the volatility in the broadly syndicated loan market as of yearend. In addition, there were numerous other net appreciations across the overall portfolio, resulting in the non-CLO portfolio total value increasing by 0.7% in total during the quarter. Return on equity remains an important performance indicator for us which includes both realized and unrealized gains. Our return on equity was 13.9% for the last 12 months. Both our adjusted LTM NII of 7.8% and our ROE is well above our blended average cost of capital of 4.6% as of yearend. Competition remains fierce, but we continue to find opportunities to earn above our cost of capital. Total expenses, excluding interest and debt financing expenses, both management fees and incentive fees and income taxes remained unchanged at $1.8 million for this quarter compared to last year. This represented 0.9% of average total assets on an annualized basis, down from 1.1% last year. We have also again added the KPI slides starting from Slides 28 through 31 in the appendix at the end of the presentation that shows our income statement and balance sheet metrics for the past nine quarters and the upward trends we have maintained. Of particular note is Slide 31 highlighting how our net interest margin run rate has continued to increase and has almost quadrupled since Saratoga took over management of the BDC and also increased by 2% in the past 12 months, while still not yet receiving the benefit of putting to work our significant amount of Q4 undeployed cash. Slide 4 highlights these same key performance metrics for the full fiscal year. When adjusting for the incentive fee accrual related to net capital gains and the interest on the redeemed SAF baby bonds during the call period this year, adjusted NII of $25.7 million was up 13.9% from $22.6 million as compared to last year. Adjusted NII per share was $2.24, up $0.22 from $2.02 and adjusted NII yield was 7.8%, up 20 basis points from 7.6%. For fiscal year 2022, we experienced a net gain on investments of $28.2 million dollars, or $2.46 per weighted average shape, and a $2.4 million realized loss on the repayment of various pieces of debt, or $0.21 per weighted average share, resulting in a total increase in net assets from operations of $45.7 million or $3.99 per share. This net gain on investments included $13.4 million in net realized gains, and $17 million in net unrealized appreciation for this year. Moving on to Slide 6, NAV was $355.8 million dollars as of this quarter end, a $13.2 million increase from last quarter, and a $51.6 million increase from the same quarter last year, primarily driven by net realized and unrealized gains and accretive ATM equity issuances. During Q4 approximately 390,000, shares were sold for net proceeds of $11.5 million at an average price of $29.31, while 50,000 shares were repurchased at an average price of $25.86. NAV per share was $29.53 as of yearend, up from $27.25 12 months ago. This chart now also includes our historical NAV per share, which highlights our NAV per share has increased 17 of the past 19 quarters. Our net asset value has steadily increased since 2011 and this growth has all been accretive as demonstrated by the consistent increase in NAV per share. We continue to benefit from our history of consistent realized and unrealized gains. On Slide seven, you will see a simple reconciliation of the major changes in NII and NAV per share on a sequential quarterly basis. Starting at the top, adjusted NII per share remained the same at $0.53 per share a $0.07 increase in non-CLO net interest income from the partial impact of higher AUM and a $0.07 increase in other income from higher originations were offset by a $0.02 decrease in CLO interest income reflecting the volatile public markets, a $0.02 increase in base management fees and a $0.04 increase in operating expenses to more normalized levels. In addition, our 2021 excise tax resulted in a $0.04 reduction, and the net new shares issued led to a $0.02 net dilution. Moving on to the lower half of the slide, this reconciles the $0.16 NAV per share increase for the quarter. The $0.48 of GAAP NII and $0.24 of net realized gains and unrealized appreciation on investments were primarily offset by the $0.53 dividend paid in Q4. On Slide 8, you will see the same reconciliation, but now on a sequential annual basis. Starting at the top adjusted NII per share increased from $2.02 per share last year to $2.24 per share this year. The primary drivers were a $0.44 increase in other income from higher originations offset by a $0.20 cent increase in base management fees from higher average AUM. There was also a net 0.06 dilution from increased share count for the year. On the lower half of the slide, this reconciles the $2.08 NAV per share increase for the year. The $1.74 of GAAP NII and $2.66 of net realized gains and unrealized appreciation were partially offset by a $0.06 net expense related to deferred taxes on unrealized appreciation. The $1.92 dividend paid during the year, a $0.25 income tax provision from realized gains in our tax blockers and a $0.21 realized loss on extinguishment of debt. Slide 9 outlines the dry powder available to us as of yearend, which totaled $166.4 million. This was spread between our available cash, undrawn SBA debentures and undrawn secured credit facility. This quarter end level of available liquidity allows us to grow our assets by an additional 20% without the need for external financing, with $53 million of it being cash and that's fully accretive to NII when deployed, and $76 million of it SBA debentures with its low cost pricing also very accretive. In January, we closed an institutional bond offering of $75 million, 4.35% notes due 2027, and just last week we closed $87.5 million 6.0% baby bond due 2027. This baby bond liquidity is accretive to our year end liquidity outlined on this slide. We remain pleased with our available liquidity and leverage position including our access to diverse sources of both public and private liquidity, and especially taking into account the overall conservative nature of our balance sheet, the fact that almost all our debt is long-term in nature with no non-SBIC debt maturing within the next three years, and importantly, that almost all our debt is fixed rate in this rising rate environment. Now I would like to move on to Slides 10 through 13 and review the composition and yield of our investment portfolio. Slide 10 highlights that we now have $818 million of AUM at fair value or $796 million at cost invested in 45 portfolio companies, one CLO fund and one joint venture. Our first lien percentage is 77% of our total investments, of which 12% is in first lien lost out positions. On Slide 11, you can see how the yield on our core BDC assets, excluding our CLO, as well as our total assets yield has dropped below 9% this year. This is primarily due to continued tightening of spreads in our market with another 50 basis points this quarter. In addition, our equity positions this fiscal year have increased significantly from 6.0% to 10.7% in Q4. Much of that is due to the appreciation in existing equity valuations resulting from strong performance, while some of the equity increase is also in the form of preferred equity that earns dividend income that is reflected in other income in the P&L rather than interest income. As a reminder, 97.5% of our interest earning portfolio is variable rate and 75% of our investments have a LIBOR flow of 100 basis points or less. So with a three-month LIBOR breaking through 100 basis points recently, we expect to see the earnings impact of rising rates to our NII shortly. Our 10-K outlines the pro forma impact of rate increases to our portfolio, including a $0.17 annual benefit to NII, net of incentive fee for the first 100 basis points. The CLO yield decreased to 10.5% quarter-on-quarter reflecting current market performance. The CLO is currently performing and current. Slide 12 shows how our investments are widely diversified through the US. And on Slide 13 you can see the industry breadth and diversity that our portfolio represents. Our investments are spread over 38 distinct industries with a large focus on healthcare software, IT services and education, consumer and healthcare services. In addition to our investments in the CLO and JV, which are included here as structured finance securities. Of our total investment portfolio 10.7% consists of equity interests, which remain a very important part of our overall investment strategy. For the past 10 fiscal years, we have a combined $73 million of net realized gains from the sale of equity interests or sale or early redemption of other investments. And over two thirds of these historical total gains were fully accretive to NAV due to the unused capital loss carry forwards that were carried over from when Saratoga took over management of the BDC. And to a smaller degree the Elyria realization last year and My Alarm Center final write down this year. We continue to have $1 million capital loss remaining at year end. This consistent realized gain performance highlights our portfolio credit quality has helped grow our NAV, and is reflected in our healthy long-term ROE. That concludes my financial and portfolio review. I will now turn the call over to Michael Grisius, our Chief Investment Officer for an overview of the investment market.